Endotypes in chronic spontaneous urticaria

Area of Science:

• Immunology
• Dermatology
• Allergology

Background:

• Chronic spontaneous urticaria (CSU) pathogenesis is debated, with proposed mechanisms involving mast cell and basophil activation.
• Two distinct pathogenic pathways, type Ia and type IIb, have been suggested.
• Type Ia involves IgE antibodies to thyroperoxidase or interleukin 24 (IL24), while type IIb involves IgG antibodies to the IgE receptor and complement activation via C5a.

Purpose of the Study:

• To critically evaluate the evidence supporting the type Ia pathogenic mechanism in CSU.
• To assess the role of the type IIb mechanism in CSU pathogenesis.
• To clarify the contribution of different immunological pathways to CSU.

Main Methods:

• Review of existing literature on CSU pathogenesis, IgE, and IgG antibodies.
• Analysis of data regarding patient responses to Omalizumab.
• Examination of in vitro studies on basophil histamine release.

Main Results:

• Insufficient reproducible data exists to support type Ia mechanism as pathogenic for CSU.
• Evidence for thyroid antigen in skin is limited, and IL24's role is unclear.
• The type IIb mechanism, involving IgG antibodies to the IgE receptor and C5a, accounts for a significant portion of CSU patients.
• Omalizumab efficacy trials did not show response differences based on IgE levels.

Conclusions:

• The type Ia mechanism for CSU is not well-supported by current evidence due to conflicting data and lack of reproducibility.
• The type IIb mechanism, involving IgG antibodies to the IgE receptor and C5a, appears to be a more significant factor in CSU pathogenesis.
• Further research is required to fully elucidate the complex immunological pathways involved in CSU.